Autoimmune hepatitis and multiple sclerosis: a coincidental association?-Reference-Cited by-同舟云学术

Autoimmune hepatitis and multiple sclerosis: a coincidental association?

Published:2005-12 Issue:6 Volume:11 Page:691-693
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

de Seze J¹,Canva-Delcambre V²,Fajardy I³,Delalande S⁴,Stojkovic T⁴,Godet E⁵,Vermersch P⁴

Affiliation:

1. Department of Neurology, University of Lille, France,

2. Department of Hepatology, University of Lille, France

3. Department of Biochemistry, University of Lille, France

4. Department of Neurology, University of Lille, France

5. Department of Neurology, Hospital of Metz, France

Abstract

In the present study we report, as part of a large multiple sclerosis (MS) cohort (1800 patients), three cases of untreated patients who developed autoimmune hepatitis (AIH). The prevalence of AIH in the general population is about 0.0169% and seems to be higher in our MS cohort (0.17%). We suggest that a liver biopsy should systematically be performed in untreated MS patients with a sustained increase of liver enzyme.

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1191/1352458505ms1239oa

Reference16 articles.

1. Multiple sclerosis, interferon beta and clinical thyroid dysfunction

2. Co-occurrence of multiple sclerosis and myasthenia gravis in British C olumbia

3. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis

4. Hépatite auto-immune associée à une sclérose en plaques

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute onset of autoimmune hepatitis after initiation of B cell depletion therapy in multiple sclerosis;Neuroimmunology Reports;2024

2. Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System;Pharmaceuticals;2023-07-27

3. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives;Clinical and Experimental Medicine;2023-07-08

4. KASL clinical practice guidelines for management of autoimmune hepatitis 2022;Clinical and Molecular Hepatology;2023-07-01

5. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders;Autoimmunity Reviews;2023-05